Zobrazeno 1 - 10
of 105
pro vyhledávání: '"Blok, M.J."'
Autor:
Hogervorst, F.B.L., van Leeuwen, F.E., Adank, M.A., Schmidt, M.K., Stommel-Jenner, D.J., de Groot, R., Vieveen, E., Collée, J.M., Geurts-Giele, W., Heemskerk-Gerritsen, B.A.M., Hooning, M.J., Boere, I.A., van Asperen, C.J., Devilee, P., van der Luijt, R.B., Wevers, M.R., Mensenkamp, A.R., de Hullu, J.A., Ausems, M.G.E.M., Koudijs, M.J., Koole, W., van Engelen, K., Gille, J.J.P., Gómez García, E.B., Blok, M.J., Berger, L.P.V., van der Hout, A.H., de Bock, G.H., Yigit, R., Siesling, S., Verloop, J., Voorham, Q.J.M., Schreurs, Maartje A.C., Schmidt, Marjanka K., Hollestelle, Antoinette, Schaapveld, Michael, van Asperen, Christi J., Ausems, Margreet G.E.M., van de Beek, Irma, Broekema, Marjoleine F., Margriet Collée, J., van der Hout, Annemieke H., van Kaam, Kim J.A.F., Komdeur, Fenne L., Mensenkamp, Arjen R., Adank, Muriel A., Hooning, Maartje J.
Publikováno v:
In Genetics in Medicine September 2024 26(9)
Autor:
Figlioli, G., Billaud, A., Ahearn, T.U., Antonenkova, N.N., Becher, H., Beckmann, M.W., Behrens, S., Benitez, J., Bermisheva, M., Blok, M.J., Bogdanova, N.V., Bonanni, B., Burwinkel, B., Camp, N.J., Campbell, A., Castelao, J.E., Cessna, M.H., Chanock, S.J., Czene, K., Devilee, P., Dork, T., Engel, C., Eriksson, M., Fasching, P.A., Figueroa, J.D., Gabrielson, M., Gago-Dominguez, M., Garcia-Closas, M., Gonzalez-Neira, A., Grassmann, F., Guenel, P., Gundert, M., Hadjisavvas, A., Hahnen, E., Hall, P., Hamann, U., Harrington, P.A., He, W., Hillemanns, P., Hollestelle, A., Hooning, M.J., Hoppe, R., Howell, A., Humphreys, K., Jager, A., Jakubowska, A., Khusnutdinova, E.K., Ko, Y.D., Kristensen, V.N., Lindblom, A., Peterlongo, Paolo
Publikováno v:
European Journal of Human Genetics, 31, 578-587. Nature Publishing Group
European Journal of Human Genetics, 31(5), 578-587. Nature Publishing Group
NBCS Collaborators 2023, ' FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women ', European journal of human genetics : EJHG, pp. 1-10 . https://doi.org/10.1038/s41431-022-01257-w
European Journal of Human Genetics, 31(5), 578-587. Nature Publishing Group
NBCS Collaborators 2023, ' FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women ', European journal of human genetics : EJHG, pp. 1-10 . https://doi.org/10.1038/s41431-022-01257-w
Evidence from literature, including the BRIDGES study, indicates that germline protein truncating variants (PTVs) in FANCM confer moderately increased risk of ER-negative and triple-negative breast cancer (TNBC), especially for women with a family hi
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Schreurs, Maartje A.C., Schmidt, Marjanka K., Hollestelle, Antoinette, Schaapveld, Michael, van Asperen, Christi J., Ausems, Margreet G.E.M., van de Beek, Irma, Broekema, Marjoleine F., Margriet Collée, J., van der Hout, Annemieke H., van Kaam, Kim J.A.F., Komdeur, Fenne L., Mensenkamp, Arjen R., Adank, Muriel A., Hooning, Maartje J., Hogervorst, F.B.L., van Leeuwen, F.E., Adank, M.A., Schmidt, M.K., Stommel-Jenner, D.J., de Groot, R., Vieveen, E., Collée, J.M., Geurts-Giele, W., Heemskerk-Gerritsen, B.A.M., Hooning, M.J., Boere, I.A., van Asperen, C.J., Devilee, P., van der Luijt, R.B., Wevers, M.R., Mensenkamp, A.R., de Hullu, J.A., Ausems, M.G.E.M., Koudijs, M.J., Koole, W., van Engelen, K., Gille, J.J.P., Gómez García, E.B., Blok, M.J., Berger, L.P.V., van der Hout, A.H., de Bock, G.H., Yigit, R., Siesling, S., Verloop, J., Voorham, Q.J.M.
Publikováno v:
Genetics in Medicine; September 2024, Vol. 26 Issue: 9
Autor:
Mavaddat, N., Antoniou, A.C., Mooij, T.M., Hooning, M.J., Heemskerk-Gerritsen, B.A., Nogues, C., Laborde, L., Breysse, E., Stoppa-Lyonnet, D., Gauthier-Villars, M., Buecher, B., Caron, O., Fourme-Mouret, E., Fricker, J.P., Lasset, C., Bonadona, V., Berthet, P., Faivre, L., Luporsi, E., Mari, V., Gladieff, L., Gesta, P., Sobol, H., Eisinger, F., Longy, M., Dugast, C., Colas, C., Coupier, I., Pujol, P., Corsini, C., Lortholary, A., Vennin, P., Adenis, C., Nguyen, T.D., Delnatte, C., Tinat, J., Tennevet, I., Limacher, J.M., Maugard, C., Bignon, Y.J., Demange, L., Penet, C., Dreyfus, H., Cohen-Haguenauer, O., Venat-Bouvet, L., Leroux, D., Zattara-Cannoni, H., Fert-Ferrer, S., Bera, O., Ellis, S., Barrowdale, D., Frost, D., Evans, D.G., Izatt, L., Adlard, J., Eeles, R., Brewer, C., Tischkowitz, M., Henderson, A., Cook, J., Eccles, D., Hogervorst, F.B.L., Collee, J.M., Asperen, C.J. van, Mensenkamp, A.R., Ausems, M.G.E.M., Meijers-Heijboer, H.E.J., Engelen, K. van, Blok, M.J., Oosterwijk, J.C., Verloop, J., Broek, E. van den, Mourits, M.J.E., Koppert, L.B., Hopper, J.L., John, E.M., Chung, W.K., Andrulis, I.L., Daly, M.B., Buys, S.S., Benitez, J., Caldes, T., Jakubowska, A., Simard, J., Singer, C.F., Tan, Y., Olah, E., Navratilova, M., Foretova, L., Gerdes, A.M., Roos-Blom, M.J., Leeuwen, F.E. van, Arver, B., Olsson, H., Schmutzler, R.K., Engel, C., Kast, K., Phillips, K.A., Terry, M.B., Milne, R.L., Goldgar, D.E., Rookus, M.A., Andrieu, N., Easton, D.F., GENEPSO, EMBRACE, HEBON, kConFab Investigators, IBCCS, kConFab, BCFR
Publikováno v:
Breast Cancer Research
Breast Cancer Research, 2020, 22 (1), pp.8. ⟨10.1186/s13058-020-1247-4⟩
Breast Cancer Research, 22(1):8. BioMed Central
Breast Cancer Research, BioMed Central, 2020, 22 (1), pp.8. ⟨10.1186/s13058-020-1247-4⟩
Breast Cancer Research, 22(1):8. BioMed Central Ltd.
Breast Cancer Research, 22, 1
HEBON 2020, ' Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk : An international prospective cohort of BRCA1 and BRCA2 mutation carriers ', Breast Cancer Research, vol. 22, no. 1, 8 . https://doi.org/10.1186/s13058-020-1247-4
Repisalud
Instituto de Salud Carlos III (ISCIII)
Breast cancer research, 22(1):8. BioMed Central Ltd.
Evans, D G & et al. 2020, ' Risk-reducing salpingo-oophorectomy, natural menopause and breast cancer risk : an international prospective cohort of BRCA1 and BRCA2 mutation carriers ', Breast Cancer Research . https://doi.org/10.1186/s13058-020-1247-4
Breast Cancer Research : BCR
Breast cancer research, 22(1):8. BioMed Central
Breast Cancer Research, 22
Breast Cancer Research, 22(1):8. BioMed Central Ltd
Breast Cancer Research, 22(1). BMC
Mavaddat, N, Antoniou, A C, Mooij, T M, Hooning, M J, Heemskerk-Gerritsen, B A, Noguès, C, Gauthier-Villars, M, Caron, O, Gesta, P, Pujol, P, Lortholary, A, Barrowdale, D, Frost, D, Evans, D G, Izatt, L, Adlard, J, Eeles, R, Brewer, C, Tischkowitz, M, Henderson, A, Cook, J, Eccles, D, van Engelen, K, Mourits, M J E, Ausems, M G E M, Koppert, L B, Hopper, J L, John, E M, Chung, W K, Andrulis, I L, Daly, M B, Buys, S S, Benitez, J, Caldes, T, Jakubowska, A, Simard, J, Singer, C F, Tan, Y, Olah, E, Navratilova, M, Foretova, L, Gerdes, A-M, Roos-Blom, M-J, Van Leeuwen, F E, Arver, B, Olsson, H, Schmutzler, R K, Engel, C, Kast, K, Phillips, K-A & GENEPSO 2020, ' Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk : an international prospective cohort of BRCA1 and BRCA2 mutation carriers ', Breast Cancer Research, vol. 22, no. 1, 8 . https://doi.org/10.1186/s13058-020-1247-4
Breast Cancer Research, Vol 22, Iss 1, Pp 1-11 (2020)
Breast Cancer Research, 2020, 22 (1), pp.8. ⟨10.1186/s13058-020-1247-4⟩
Breast Cancer Research, 22(1):8. BioMed Central
Breast Cancer Research, BioMed Central, 2020, 22 (1), pp.8. ⟨10.1186/s13058-020-1247-4⟩
Breast Cancer Research, 22(1):8. BioMed Central Ltd.
Breast Cancer Research, 22, 1
HEBON 2020, ' Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk : An international prospective cohort of BRCA1 and BRCA2 mutation carriers ', Breast Cancer Research, vol. 22, no. 1, 8 . https://doi.org/10.1186/s13058-020-1247-4
Repisalud
Instituto de Salud Carlos III (ISCIII)
Breast cancer research, 22(1):8. BioMed Central Ltd.
Evans, D G & et al. 2020, ' Risk-reducing salpingo-oophorectomy, natural menopause and breast cancer risk : an international prospective cohort of BRCA1 and BRCA2 mutation carriers ', Breast Cancer Research . https://doi.org/10.1186/s13058-020-1247-4
Breast Cancer Research : BCR
Breast cancer research, 22(1):8. BioMed Central
Breast Cancer Research, 22
Breast Cancer Research, 22(1):8. BioMed Central Ltd
Breast Cancer Research, 22(1). BMC
Mavaddat, N, Antoniou, A C, Mooij, T M, Hooning, M J, Heemskerk-Gerritsen, B A, Noguès, C, Gauthier-Villars, M, Caron, O, Gesta, P, Pujol, P, Lortholary, A, Barrowdale, D, Frost, D, Evans, D G, Izatt, L, Adlard, J, Eeles, R, Brewer, C, Tischkowitz, M, Henderson, A, Cook, J, Eccles, D, van Engelen, K, Mourits, M J E, Ausems, M G E M, Koppert, L B, Hopper, J L, John, E M, Chung, W K, Andrulis, I L, Daly, M B, Buys, S S, Benitez, J, Caldes, T, Jakubowska, A, Simard, J, Singer, C F, Tan, Y, Olah, E, Navratilova, M, Foretova, L, Gerdes, A-M, Roos-Blom, M-J, Van Leeuwen, F E, Arver, B, Olsson, H, Schmutzler, R K, Engel, C, Kast, K, Phillips, K-A & GENEPSO 2020, ' Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk : an international prospective cohort of BRCA1 and BRCA2 mutation carriers ', Breast Cancer Research, vol. 22, no. 1, 8 . https://doi.org/10.1186/s13058-020-1247-4
Breast Cancer Research, Vol 22, Iss 1, Pp 1-11 (2020)
The effect of risk-reducing salpingo-oophorectomy (RRSO) on breast cancer risk for BRCA1 and BRCA2 mutation carriers is uncertain. Retrospective analyses have suggested a protective effect but may be substantially biased. Prospective studies have had
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::897204daf2b6489f47952598d573c042
https://www.hal.inserm.fr/inserm-02445596
https://www.hal.inserm.fr/inserm-02445596
Autor:
Jonge, M.M. de, Ritterhouse, L.L., Kroon, C.D. de, Vreeswijk, M.P.G., Segal, J.P., Puranik, R., Rookus, M.A., Hogervorst, F.B.L., Leeuwen, F.E. van, Adank, M.A., Schmidt, M.K., Jenner, D.J., Collee, J.M., Ouweland, A.M.W. van den, Hooning, M.J., Boere, I.A., Asperen, C.J. van, Devilee, P., Luijt, R.B. van der, Cronenburg, T.C.T.E.F. van, Wevers, M.R., Mensenkamp, A.R., Ausems, M.G.E.M., Koudijs, M.J., Meijers-Heijboer, H.E.J., Os, T.A.M. van, Engelen, K. van, Gille, J.J.P., Gomez-Garcia, E.B., Blok, M.J., Boer, M. de, Oosterwijk, J.C., Hout, A.H. van der, Mourits, M.J., Bock, G.H. de, Siesling, S., Verloop, J., Broek, E.C. van den, Hollema, H., Smit, V.T.H.B.M., Howitt, B.E., Bosse, T., HEBON Grp
Publikováno v:
Clinical Cancer Research, 25(24), 7517-7526. AMER ASSOC CANCER RESEARCH
Clinical Cancer Research, 25, 24, pp. 7517-7526
Clinical Cancer Research, 25, 7517-7526
Clinical Cancer Research, 25(24), 7517-7526. American Association for Cancer Research Inc.
Clinical Cancer Research, 25, 24, pp. 7517-7526
Clinical Cancer Research, 25, 7517-7526
Clinical Cancer Research, 25(24), 7517-7526. American Association for Cancer Research Inc.
Purpose: Whether endometrial carcinoma (EC) should be considered part of the gBRCA1/2-associated hereditary breast and ovarian cancer (HBOC) syndrome is topic of debate. We sought to assess whether ECs occurring in gBRCA carriers are enriched for cli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29398d21d80da2ec51656a9b561913ce
https://hdl.handle.net/1887/122832
https://hdl.handle.net/1887/122832
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jhuraney, A., Velkova, A., Johnson, R.C., Kessing, B., Carvalho, R.S., Whiley, P., Spurdle, A.B., Vreeswijk, M.P.G., Caputo, S.M., Millot, G.A., Vega, A., Coquelle, N., Galli, A., Eccles, D., Blok, M.J., Pal, T., Luijt, R.B. van der, Pena, M.S., Neuhausen, S.L., Donenberg, T., Machackova, E., Thomas, S., Vallee, M., Couch, F.J., Tavtigian, S.V., Glover, J.N.M., Carvalho, M.A., Brody, L.C., Sharan, S.K., Monteiro, A.N., ENIGMA Evidence-Based Network
Publikováno v:
Journal of Medical Genetics, 52(4), 224-230
Journal of Medical Genetics
Journal of Medical Genetics, BMJ Publishing Group, 2015, 52 (4), pp.224-230. ⟨10.1136/jmedgenet-2014-102766⟩
Journal of Medical Genetics, 52(4), 224-230. BMJ Publishing Group
JOURNAL OF MEDICAL GENETICS, 52(4), 224-230. BMJ PUBLISHING GROUP
Journal of Medical Genetics, 52, 224. BMJ Publishing Group
Journal of Medical Genetics
Journal of Medical Genetics, BMJ Publishing Group, 2015, 52 (4), pp.224-230. ⟨10.1136/jmedgenet-2014-102766⟩
Journal of Medical Genetics, 52(4), 224-230. BMJ Publishing Group
JOURNAL OF MEDICAL GENETICS, 52(4), 224-230. BMJ PUBLISHING GROUP
Journal of Medical Genetics, 52, 224. BMJ Publishing Group
BACKGROUND: Inactivating germline mutations in the tumour suppressor gene BRCA1 are associated with a significantly increased risk of developing breast and ovarian cancer. A large number (>1500) of unique BRCA1 variants have been identified in the po